Developer docs
API playgroundTry for free, no card

Search company profiles

Innovative Trials

Full company profile

uuid000avvc

Namestring
Innovative Trials
Legal namestring
Innovative Solutions Group Limited
Company typeenum
Private
Founded yearint
2010
Descriptiontext

Innovative Trials is a clinical trial patient recruitment and retention specialist founded in 2010 and headquartered in Letchworth, United Kingdom, with a regional office in Raleigh, North Carolina opened in 2022. The company delivers bespoke patient recruitment strategies for pharmaceutical, biotech, and Contract Research Organisation (CRO) clients, supported by a global network of Clinical Enrolment Managers (CEMs) covering approximately 70 countries and 65 languages. Core service lines comprise Site Optimization (CEM deployment, recruitment coaching, chart review), Referral Support (HCP networks, study websites, pre-screeners), and Community Engagement (patient advocacy groups, digital campaigns, diversity outreach), supplemented by two newer modules: the Navigator Service (launched October 2023), which provides dedicated patient navigators and secondary prescreening, and the Retention Patch Program (launched 2023), a pediatric retention initiative developed with the Oliver Patch Project.

The underlying technology stack centers on operational tooling rather than a unified software platform: in-house study website and pre-screener development, digital campaign execution, and AI-assisted secondary prescreening within the Navigator module, backed by data accumulated across ~200 clinical trials and ~40,000 recruited patients. The company employs 60+ staff in the UK and approximately 65 personnel stationed overseas, with no disclosed private equity or venture capital investment; ownership remains with co-founders Kate Shaw (CEO) and David Watkins (CIO), with Anita Owen appointed as first Chief Operating Officer in April 2026 and John Watkinson as first Non-Executive Chair in January 2025.

Revenue is generated through project-based professional services contracts sourced via a formal RFP process and direct consultation; pricing is not publicly disclosed and is tailored to each protocol's therapy area, geography, and complexity. Distribution is enterprise-led, with services delivered through direct deployment of CEMs to trial sites and supported by content marketing (whitepapers, webinars, case studies) and industry conference presence. The customer base includes named enterprise sponsors across large pharma and CROs as well as NHS-affiliated partners such as The Christie NHS Foundation Trust.

Short descriptiontext

Innovative Trials is a UK-based clinical trial patient recruitment and retention specialist serving pharmaceutical, biotech, and CRO clients across ~70 countries via a global Clinical Enrolment Manager network, three core service lines (Site Optimization, Referral Support, Community Engagement), and patient-support modules including the Navigator Service and Retention Patch Program.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
101–250
akta.pro rankint
HeadquartersLetchworth, United Kingdom
HQ citystring
Letchworth
HQ countrystring
United Kingdom
HQ regionstring
Europe
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
clinical trial recruitment, patient enrollment services, site optimization services, patient retention programs, clinical research support
Industry3 codes
PRIMARYHLAGACAD
Clinical Trial Patient Recruitment & Retention
SECONDARYHLAGACAE
Clinical Trial Site Operations & Study Coordination
SECONDARYHLAGAAAI
Patient Recruitment, Site Feasibility & Trial Enablement CROs
NAICS code1 code
  • Scientific Research and Development Services5417
SIC code1 code
  • Services-Commercial Physical & Biological Research8731
Product category
Clinical Trial Patient Recruitment Services
GTM motion4 records

Each record includes

Type, Description, Source

Revenue model2 records
1Clinical Trial Patient Recruitment Services
TypeProfessional Services
Description

Provides bespoke patient recruitment and retention strategies for clinical trials. Services include site optimization, referral support, community engagement, and patient support programs. Revenue generated through project-based contracts with pharmaceutical companies, CROs, and biotech companies.

innovativetrials.com
2Clinical Site Optimization Services
TypeProfessional Services
Description

Clinical Enrolment Manager (CEM) support, site recruitment coaching, chart review, and provision of study materials. Services delivered through direct engagement with trial sites.

innovativetrials.com
Marketing channels7 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure
GTM typeB2B
B2B
Offering typeServices
Services
Brand1 of 3 records shown
1Navigator
Description

A patient recruitment and retention service providing personalised VIP support, guiding patients and caregivers through every step of their clinical trial journey with dedicated Patient Navigators.

innovativetrials.com
+2 more records
Core offering1 text field

Innovative Trials is a clinical trial patient recruitment and retention specialist that helps pharmaceutical companies, CROs, and biotechs accelerate patient enrollment through three core service lines: Site Optimization, Referral Support, and Community Engagement. Services are delivered via a global network of Clinical Enrolment Managers (CEMs) in 70+ countries and supplemented by specialized offerings including the Navigator patient support service and the pediatric Retention Patch Program.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 5 values shown
  • 181% increase in patient pre-screening rates (Type II Diabetes Phase IIIa rescue study)
+4 more records
Product overview1 text field

Innovative Trials is a clinical trial patient recruitment and retention company offering a portfolio of services including three core service lines (Site Optimization, Referral Support, and Community Engagement) plus specialized modules (Navigator Service and Retention Patch Program). The company operates globally in over 70 countries with Clinical Enrolment Managers providing localized support. Services range from site-level optimization and patient pre-screening to community outreach, digital campaigns, and educational resources including webinars and whitepapers. The Navigator Service provides personalized patient support, while the Retention Patch Program addresses pediatric trial retention through a partnership with Oliver Patch Project.

Product and service5 records
1Site Optimization
CategoryClinical Trial Site Optimization
Description

Clinical site optimization services delivered by Clinical Enrolment Managers (CEMs) working directly with investigator sites to accelerate patient recruitment. Includes the global CEM network (70 countries, 65 languages), patient recruitment strategy and planning, site recruitment coaching, chart review, and provision of site materials. Targeted at pharmaceutical companies, CROs, and biotechs running multi-site trials.

2Referral Support
CategoryClinical Trial Referral Services
Description

Clinical trial referral support services to maximize referral opportunities around study sites. Includes patient pathway optimization, HCP referral network development, referral material provision, referral recruitment coaching, and in-house study website and pre-screener creation. Targeted at pharmaceutical companies, CROs, and biotechs seeking to broaden patient identification beyond investigator sites.

3Community Engagement
CategoryClinical Trial Community Outreach
Description

Patient engagement solutions focused on community involvement at each step of clinical research. Includes study branding and design, Patient Advocacy Group support, community outreach, digital campaigns, patient and community insights, patient materials, and diversity and minority outreach. Targeted at pharmaceutical companies, CROs, and biotechs seeking to improve trial accessibility and diversity.

4Navigator Service
CategoryPatient Support Service
Description

Personalized patient and caregiver support service providing VIP assistance throughout the clinical trial journey. Features dedicated Patient Navigators for all study-related inquiries and secondary prescreening capabilities. Available globally with multilingual support. Targeted at pharmaceutical companies, CROs, and biotechs seeking to improve patient experience, retention, and pre-screening conversion.

5Retention Patch Program
CategoryPediatric Patient Retention Program
Description

Global pediatric retention initiative operated in partnership with the Oliver Patch Project non-profit. Children enrolled in pediatric clinical trials receive collectible retention patches at enrollment and at each study milestone completed, designed to boost retention rates in pediatric clinical trials. Targeted at pharmaceutical companies, CROs, and biotechs running pediatric clinical trials.

Scale indicator10 records

Each record includes

Type, Value, Description, Source

Partnership6 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2024-02-01
Description

UK charity partnership supporting GOSH Charity's Build it. Beat it. appeal to raise £300m for a new world-leading Children's Cancer Centre at Great Ormond Street Hospital. Partnership began formally in June 2023 and was originally intended to last 12 months. The company raises funds through internal activities and events to support pediatric cancer research and care.

Strategic tierFlagshipTypeStrategic or Co-development PartnerAnnounced on2023-09-01
Description

First-ever US-based charity partnership committed to helping improve blood cancer care and advance research into multiple myeloma with the aim of finding cures. Partnership lasted until May 2024 with commitment to raise $4,000. MMRF has committed over $500 million for research and helped bring 15+ FDA-approved therapies to market.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2023-01-01
Description

US charity partnership extending the Retention Patch Program launched in 2023 - a joint initiative to boost clinical trial patient retention in pediatric studies. Children enrolled in pediatric clinical trials receive patches for milestones. The company commits to donating $6 to the Oliver Patch Project for each child enrolled where sponsors commission the Retention Patch Program.

Strategic tierMinorTypeOthers
Description

Previous UK charity partnership.

Strategic tierMinorTypeOthers
Description

Previous UK charity partnership.

Strategic tierMinorTypeOthers
Description

Previous UK charity partnership.

Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Parexel is a major global CRO offering comprehensive clinical trial services including patient recruitment and retention programs — competing for the same pharma and biotech sponsors as Innovative Trials.

TypeDirect peer
Description

BBK Worldwide is a long-standing clinical trial patient recruitment and engagement agency offering similar patient-centric recruitment, site optimization, and patient engagement services to pharma and CRO sponsors globally.

TypeDirect peer
Description

ClinEdge is a clinical research services company specializing in patient recruitment, retention, and decentralized trial services for biotech and pharma sponsors — closely comparable in scale and service offering.

TypeBroad incumbent
Description

IQVIA is the world's largest CRO offering full-service clinical development including bundled patient recruitment, site management, and decentralized trial capabilities — directly competitive for sponsor RFPs.

5Antidote (formerly TrialReach)
TypeEmerging player
Description

Antidote is a digital patient recruitment platform that matches patients to clinical trials through online search and AI-driven matching. It represents the tech-enabled alternative to Innovative Trials' CEM-led model.

TypeBroad incumbent
Description

ICON plc is a top-3 global CRO providing full-service clinical trial execution including patient recruitment, feasibility, and site optimization — competing with Innovative Trials on enterprise RFPs.

TypeBroad incumbent
Description

Labcorp Drug Development is a global CRO with extensive clinical trial services including site management, patient recruitment, and central laboratory services — competing for enterprise clinical trial contracts.

TypeBroad incumbent
Description

Syneos Health is a fully integrated biopharmaceutical solutions organization offering clinical development and commercialization services including patient recruitment — competing for large pharma RFPs.

9MMG (MMG Global)
TypeDirect peer
Description

MMG is a clinical trial patient recruitment and retention company providing global site engagement and patient-centric services — comparable peer in the patient recruitment specialty services space.

TypeEmerging player
Description

AutoCruitment is a digital patient recruitment company using targeted digital advertising and AI-driven pre-screening to accelerate enrollment — represents the tech-native alternative to traditional recruitment models.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers3 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI capability5 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles6 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Innovative Trials

Clinical Trial Patient Recruitment Servicesinnovativetrials.com

Innovative Trials is a UK-based clinical trial patient recruitment and retention specialist serving pharmaceutical, biotech, and CRO clients across ~70 countries via a global Clinical Enrolment Manager network, three core service lines (Site Optimization, Referral Support, Community Engagement), and patient-support modules including the Navigator Service and Retention Patch Program.

What Innovative Trials does

Innovative Trials is a clinical trial patient recruitment and retention specialist founded in 2010 and headquartered in Letchworth, United Kingdom, with a regional office in Raleigh, North Carolina opened in 2022. The company delivers bespoke patient recruitment strategies for pharmaceutical, biotech, and Contract Research Organisation (CRO) clients, supported by a global network of Clinical Enrolment Managers (CEMs) covering approximately 70 countries and 65 languages. Core service lines comprise Site Optimization (CEM deployment, recruitment coaching, chart review), Referral Support (HCP networks, study websites, pre-screeners), and Community Engagement (patient advocacy groups, digital campaigns, diversity outreach), supplemented by two newer modules: the Navigator Service (launched October 2023), which provides dedicated patient navigators and secondary prescreening, and the Retention Patch Program (launched 2023), a pediatric retention initiative developed with the Oliver Patch Project.

The underlying technology stack centers on operational tooling rather than a unified software platform: in-house study website and pre-screener development, digital campaign execution, and AI-assisted secondary prescreening within the Navigator module, backed by data accumulated across ~200 clinical trials and ~40,000 recruited patients. The company employs 60+ staff in the UK and approximately 65 personnel stationed overseas, with no disclosed private equity or venture capital investment; ownership remains with co-founders Kate Shaw (CEO) and David Watkins (CIO), with Anita Owen appointed as first Chief Operating Officer in April 2026 and John Watkinson as first Non-Executive Chair in January 2025.

Revenue is generated through project-based professional services contracts sourced via a formal RFP process and direct consultation; pricing is not publicly disclosed and is tailored to each protocol's therapy area, geography, and complexity. Distribution is enterprise-led, with services delivered through direct deployment of CEMs to trial sites and supported by content marketing (whitepapers, webinars, case studies) and industry conference presence. The customer base includes named enterprise sponsors across large pharma and CROs as well as NHS-affiliated partners such as The Christie NHS Foundation Trust.

Innovative Trials firmographics

Firmographics
Name
Innovative Trials
Legal name
Innovative Solutions Group Limited
Website
https://innovativetrials.com
Company type
Private
Founded year
2010
Operating status
Operating
Headcount range
101–250 employees
Short description
Innovative Trials is a UK-based clinical trial patient recruitment and retention specialist serving pharmaceutical, biotech, and CRO clients across ~70 countries via a global Clinical Enrolment Manager network, three core service lines (Site Optimization, Referral Support, Community Engagement), and patient-support modules including the Navigator Service and Retention Patch Program.
Ownership category
akta.pro rank

Innovative Trials industry classification

Industry
Product category
Clinical Trial Patient Recruitment Services
NAICS
Scientific Research and Development Services (5417)
SIC
Services-Commercial Physical & Biological Research (8731)
akta.pro industry
PRIMARYHLAGACAD
Clinical Trial Patient Recruitment & Retention
SECONDARYHLAGACAE
Clinical Trial Site Operations & Study Coordination
SECONDARYHLAGAAAI
Patient Recruitment, Site Feasibility & Trial Enablement CROs

Keywords

  • Clinical trial recruitment
  • Patient enrollment services
  • Site optimization services
  • Patient retention programs
  • Clinical research support

Where Innovative Trials is headquartered

Location

Headquarters

HQ city
Letchworth
HQ country
United Kingdom
HQ region
Europe

Offices2 records

Markets served

Innovative Trials business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure

Revenue model

  1. Clinical Trial Patient Recruitment Services: Provides bespoke patient recruitment and retention strategies for clinical trials. Services include site optimization, referral support, community engagement, and patient support programs. Revenue generated through project-based contracts with pharmaceutical companies, CROs, and biotech companies.
  2. Clinical Site Optimization Services: Clinical Enrolment Manager (CEM) support, site recruitment coaching, chart review, and provision of study materials. Services delivered through direct engagement with trial sites.

Go-to-market motion4 records

Distribution channels3 records

Marketing channels7 records

Innovative Trials product offering

Product offering

Core offering

Innovative Trials is a clinical trial patient recruitment and retention specialist that helps pharmaceutical companies, CROs, and biotechs accelerate patient enrollment through three core service lines: Site Optimization, Referral Support, and Community Engagement. Services are delivered via a global network of Clinical Enrolment Managers (CEMs) in 70+ countries and supplemented by specialized offerings including the Navigator patient support service and the pediatric Retention Patch Program.

Product overview

Innovative Trials is a clinical trial patient recruitment and retention company offering a portfolio of services including three core service lines (Site Optimization, Referral Support, and Community Engagement) plus specialized modules (Navigator Service and Retention Patch Program). The company operates globally in over 70 countries with Clinical Enrolment Managers providing localized support. Services range from site-level optimization and patient pre-screening to community outreach, digital campaigns, and educational resources including webinars and whitepapers. The Navigator Service provides personalized patient support, while the Retention Patch Program addresses pediatric trial retention through a partnership with Oliver Patch Project.

Differentiator

Problem solved

Functional benefit

Brands

  • Navigator: A patient recruitment and retention service providing personalised VIP support, guiding patients and caregivers through every step of their clinical trial journey with dedicated Patient Navigators.
  • Retention Patch Program
  • Innovative Trials Academy

Products and services

  • Site Optimization Clinical site optimization services delivered by Clinical Enrolment Managers (CEMs) working directly with investigator sites to accelerate patient recruitment. Includes the global CEM network (70 countries, 65 languages), patient recruitment strategy and planning, site recruitment coaching, chart review, and provision of site materials. Targeted at pharmaceutical companies, CROs, and biotechs running multi-site trials.
  • Referral Support Clinical trial referral support services to maximize referral opportunities around study sites. Includes patient pathway optimization, HCP referral network development, referral material provision, referral recruitment coaching, and in-house study website and pre-screener creation. Targeted at pharmaceutical companies, CROs, and biotechs seeking to broaden patient identification beyond investigator sites.
  • Community Engagement Patient engagement solutions focused on community involvement at each step of clinical research. Includes study branding and design, Patient Advocacy Group support, community outreach, digital campaigns, patient and community insights, patient materials, and diversity and minority outreach. Targeted at pharmaceutical companies, CROs, and biotechs seeking to improve trial accessibility and diversity.
  • Navigator Service Personalized patient and caregiver support service providing VIP assistance throughout the clinical trial journey. Features dedicated Patient Navigators for all study-related inquiries and secondary prescreening capabilities. Available globally with multilingual support. Targeted at pharmaceutical companies, CROs, and biotechs seeking to improve patient experience, retention, and pre-screening conversion.
  • Retention Patch Program Global pediatric retention initiative operated in partnership with the Oliver Patch Project non-profit. Children enrolled in pediatric clinical trials receive collectible retention patches at enrollment and at each study milestone completed, designed to boost retention rates in pediatric clinical trials. Targeted at pharmaceutical companies, CROs, and biotechs running pediatric clinical trials.

Quantifiable outcome

  • 181% increase in patient pre-screening rates (Type II Diabetes Phase IIIa rescue study)
  • +4 more outcomes

Companies that use Innovative Trials

Customer profile

Named customers3 records

Segments3 records

Ideal customer profiles3 records

Innovative Trials technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability5 records

Feature4 records

Innovative Trials partnerships and signals

Strategic signal

Partnerships

Six partnerships are on record, tiered core, flagship and minor.

  • Great Ormond Street Hospital Children’s Charity (GOSH Charity)coreStrategic or Co-development Partner · 1 February 2024UK charity partnership supporting GOSH Charity's Build it. Beat it. appeal to raise £300m for a new world-leading Children's Cancer Centre at Great Ormond Street Hospital. Partnership began formally in June 2023 and was originally intended to last 12 months. The company raises funds through internal activities and events to support pediatric cancer research and care.
  • Multiple Myeloma Research Foundation (MMRF)flagshipStrategic or Co-development Partner · 1 September 2023First-ever US-based charity partnership committed to helping improve blood cancer care and advance research into multiple myeloma with the aim of finding cures. Partnership lasted until May 2024 with commitment to raise $4,000. MMRF has committed over $500 million for research and helped bring 15+ FDA-approved therapies to market.
  • Oliver Patch ProjectcoreStrategic or Co-development Partner · 1 January 2023US charity partnership extending the Retention Patch Program launched in 2023 - a joint initiative to boost clinical trial patient retention in pediatric studies. Children enrolled in pediatric clinical trials receive patches for milestones. The company commits to donating $6 to the Oliver Patch Project for each child enrolled where sponsors commission the Retention Patch Program.
  • Crohn’s and Colitis UKminorOthersPrevious UK charity partnership.
  • Alzheimer's Research UKminorOthersPrevious UK charity partnership.
  • MS SocietyminorOthersPrevious UK charity partnership.

Scale indicators10 records

Recent moves7 records

Expansion highlights5 records

Innovative Trials competitors and assessment

Company assessment

Broad incumbents

  • Parexel International: Parexel is a major global CRO offering comprehensive clinical trial services including patient recruitment and retention programs — competing for the same pharma and biotech sponsors as Innovative Trials.
  • IQVIA: IQVIA is the world's largest CRO offering full-service clinical development including bundled patient recruitment, site management, and decentralized trial capabilities — directly competitive for sponsor RFPs.
  • ICON plc: ICON plc is a top-3 global CRO providing full-service clinical trial execution including patient recruitment, feasibility, and site optimization — competing with Innovative Trials on enterprise RFPs.
  • Labcorp Drug Development (formerly Covance): Labcorp Drug Development is a global CRO with extensive clinical trial services including site management, patient recruitment, and central laboratory services — competing for enterprise clinical trial contracts.
  • Syneos Health: Syneos Health is a fully integrated biopharmaceutical solutions organization offering clinical development and commercialization services including patient recruitment — competing for large pharma RFPs.

Direct peers

  • BBK Worldwide: BBK Worldwide is a long-standing clinical trial patient recruitment and engagement agency offering similar patient-centric recruitment, site optimization, and patient engagement services to pharma and CRO sponsors globally.
  • ClinEdge: ClinEdge is a clinical research services company specializing in patient recruitment, retention, and decentralized trial services for biotech and pharma sponsors — closely comparable in scale and service offering.
  • MMG (MMG Global): MMG is a clinical trial patient recruitment and retention company providing global site engagement and patient-centric services — comparable peer in the patient recruitment specialty services space.

Emerging players

  • Antidote (formerly TrialReach): Antidote is a digital patient recruitment platform that matches patients to clinical trials through online search and AI-driven matching. It represents the tech-enabled alternative to Innovative Trials' CEM-led model.
  • AutoCruitment: AutoCruitment is a digital patient recruitment company using targeted digital advertising and AI-driven pre-screening to accelerate enrollment — represents the tech-native alternative to traditional recruitment models.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Innovative Trials social profiles

Digital presence

Innovative Trials financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Innovative Trials leadership team

Management profile

Number of profiles

Profiles6 records

Innovative Trials funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Innovative Trials M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Innovative Trials

What does Innovative Trials do?

Innovative Trials is a clinical trial patient recruitment and retention specialist that helps pharmaceutical companies, CROs, and biotechs accelerate patient enrollment through three core service lines: Site Optimization, Referral Support, and Community Engagement. Services are delivered via a global network of Clinical Enrolment Managers (CEMs) in 70+ countries and supplemented by specialized offerings including the Navigator patient support service and the pediatric Retention Patch Program.

Is Innovative Trials a public or private company?

Innovative Trials is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Innovative Trials founded?

Innovative Trials was founded in 2010. It employs 101 to 250 people.

Where is Innovative Trials based?

Innovative Trials is headquartered in Letchworth, United Kingdom, in the Europe region.

How does Innovative Trials make money?

Two revenue lines are on record. Clinical Trial Patient Recruitment Services are the primary driver. The others are clinical Site Optimization Services.

Who are Innovative Trials's main competitors?

Broad incumbents on record are Parexel International, IQVIA, ICON plc, Labcorp Drug Development (formerly Covance) and Syneos Health. Direct peers are BBK Worldwide, ClinEdge and MMG (MMG Global). Emerging players are Antidote (formerly TrialReach) and AutoCruitment.

Does Innovative Trials have an API?

No public API is recorded for Innovative Trials.

What industry is Innovative Trials in?

Innovative Trials's product category is Clinical Trial Patient Recruitment Services. Its primary akta.pro industry code is HLAGACAD, Clinical Trial Patient Recruitment & Retention, with a secondary code of HLAGACAE, Clinical Trial Site Operations & Study Coordination. Its NAICS code is 5417 and its SIC code is 8731.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
PrwebInnovative Trials launches global education programme as survey exposes major misconceptions about clinical trialsInnovative Trials launched the Innovative Trials Academy to educate the public about clinical trials, following a survey of 4,000 UK and US adults. The survey found 73% of UK adults believe they understand trials, yet 43% think participants are paid, 27% think only one trial is needed, and 60% don't know participants can leave at any time.InnovativetrialsClinical Trial Case StudiesThe article presents a series of case studies from Innovative Trials, detailing how the company assisted various pharmaceutical sponsors in overcoming patient recruitment and enrollment challenges for clinical trials. These projects span multiple therapeutic areas, including oncology, rare diseases, and women's health, involving sites across countries such as the USA, Canada, Australia, and locations in Europe and Asia. The content highlights specific metrics of success, such as increased randomization rates and accelerated enrollment timelines, achieved through strategies like boot-on-the-ground support and digital campaigns.InnovativetrialsFive strategies we’ve learned in our 15 years to unlock clinical trial patient recruitmentInnovative Trials, alongside Soglia and Monroe Biomedical Research, outlined five strategic pillars for improving clinical trial patient recruitment and retention after 15 years in the industry. The strategies emphasize integrating empathy, patient education, community outreach for diversity, strategic technology use, and support to prevent site burnout. The discussion highlights that while AI and digital tools offer efficiency, human-centered approaches remain critical for overcoming distrust and ensuring inclusivity.InnovativetrialsRevolutionize patient recruitment and retention with NavigatorInnovative Trials, a UK-based clinical trial recruitment and retention firm, announced on 9 October a new patient-first service called Navigator, offering pre-screening support for digital referrals and ongoing patient and caregiver retention. The service, based on an 18-month US pilot, is rated 93% satisfied by participants and 9 out of 10 by sites.outsourcing-pharma.com'First of its kind' long-term, direct patient-facing support service launched by Innovative TrialsInnovative Trials launched its Navigator service, a long-term patient-facing support for clinical trials from referral to endpoint. The service, piloted in the US, aims to boost recruitment and retention, addressing delays in over four in five studies. It provides pre-screening and retention support via local patient navigators.